Bifogade filer
Kurs & Likviditet
Kalender
2025-12-04 | Årsstämma |
2025-11-04 | Bokslutskommuniké 2025 |
2025-08-19 | Kvartalsrapport 2025-Q3 |
2025-04-06 | Kvartalsrapport 2025-Q2 |
2025-02-04 | Kvartalsrapport 2025-Q1 |
2024-12-05 | Årsstämma |
2024-11-05 | Bokslutskommuniké 2024 |
2024-08-20 | Kvartalsrapport 2024-Q3 |
2024-05-13 | X-dag halvårsutdelning COLO B 5 |
2024-05-07 | Kvartalsrapport 2024-Q2 |
2024-02-09 | Kvartalsrapport 2024-Q1 |
2023-12-08 | X-dag halvårsutdelning COLO B 16 |
2023-12-07 | Årsstämma |
2023-11-09 | Bokslutskommuniké 2023 |
2023-08-17 | Kvartalsrapport 2023-Q3 |
2023-05-15 | X-dag halvårsutdelning COLO B 5 |
2023-05-11 | Kvartalsrapport 2023-Q2 |
2023-02-03 | Kvartalsrapport 2023-Q1 |
2022-12-02 | X-dag halvårsutdelning COLO B 15 |
2022-12-01 | Årsstämma |
2022-11-07 | Bokslutskommuniké 2022 |
2022-08-17 | Kvartalsrapport 2022-Q3 |
2022-05-09 | X-dag halvårsutdelning COLO B 5 |
2022-05-05 | Kvartalsrapport 2022-Q2 |
2022-01-25 | Kvartalsrapport 2022-Q1 |
2021-12-03 | X-dag halvårsutdelning COLO B 14 |
2021-12-02 | Årsstämma |
2021-11-01 | Bokslutskommuniké 2021 |
2021-08-18 | Kvartalsrapport 2021-Q3 |
2021-05-10 | X-dag halvårsutdelning COLO B 5 |
2021-05-06 | Kvartalsrapport 2021-Q2 |
2021-02-06 | Kvartalsrapport 2021-Q1 |
2020-12-04 | X-dag halvårsutdelning COLO B 13 |
2020-12-03 | Årsstämma |
2020-11-03 | Bokslutskommuniké 2020 |
2020-08-18 | Kvartalsrapport 2020-Q3 |
2020-05-11 | X-dag halvårsutdelning COLO B 5 |
2020-05-06 | Kvartalsrapport 2020-Q2 |
2020-02-06 | Kvartalsrapport 2020-Q1 |
2019-12-06 | X-dag halvårsutdelning COLO B 12 |
2019-12-05 | Årsstämma |
2019-11-05 | Bokslutskommuniké 2019 |
2019-08-14 | Kvartalsrapport 2019-Q3 |
2019-05-06 | X-dag halvårsutdelning COLO B 5 |
2019-05-02 | Kvartalsrapport 2019-Q2 |
2019-02-05 | Kvartalsrapport 2019-Q1 |
2018-12-06 | X-dag halvårsutdelning COLO B 11 |
2018-12-05 | Årsstämma |
2018-11-01 | Bokslutskommuniké 2018 |
2018-08-08 | Kvartalsrapport 2018-Q3 |
2018-05-07 | X-dag halvårsutdelning COLO B 5 |
2018-05-03 | Kvartalsrapport 2018-Q2 |
2018-02-01 | Kvartalsrapport 2018-Q1 |
2017-12-08 | X-dag halvårsutdelning COLO B 10.5 |
2017-12-07 | Årsstämma |
2017-11-02 | Bokslutskommuniké 2017 |
2017-08-16 | Kvartalsrapport 2017-Q3 |
2017-05-08 | X-dag halvårsutdelning COLO B 4.5 |
2017-05-03 | Kvartalsrapport 2017-Q2 |
2017-02-01 | Kvartalsrapport 2017-Q1 |
2016-12-06 | X-dag halvårsutdelning COLO B 9 |
2016-12-05 | Årsstämma |
2016-11-02 | Bokslutskommuniké 2016 |
2016-08-16 | Kvartalsrapport 2016-Q3 |
2016-05-09 | X-dag halvårsutdelning COLO B 4.5 |
2016-05-03 | Kvartalsrapport 2016-Q2 |
2016-02-02 | Kvartalsrapport 2016-Q1 |
2015-12-10 | X-dag halvårsutdelning COLO B 8 |
2015-12-09 | Årsstämma |
2015-11-03 | Bokslutskommuniké 2015 |
2015-08-11 | Kvartalsrapport 2015-Q3 |
2015-05-07 | X-dag halvårsutdelning COLO B 4.5 |
2015-05-05 | Kvartalsrapport 2015-Q2 |
2015-01-29 | Kvartalsrapport 2015-Q1 |
2014-12-05 | X-dag halvårsutdelning COLO B 7.5 |
2014-12-04 | Årsstämma |
2014-10-30 | Bokslutskommuniké 2014 |
2014-05-08 | X-dag halvårsutdelning COLO B 4 |
2013-12-06 | X-dag halvårsutdelning COLO B 7 |
2013-12-05 | Årsstämma |
2013-10-31 | Bokslutskommuniké 2013 |
2013-08-13 | Kvartalsrapport 2013-Q3 |
2013-05-06 | X-dag halvårsutdelning COLO B 3 |
2013-04-30 | Kvartalsrapport 2013-Q2 |
2013-01-30 | Kvartalsrapport 2013-Q1 |
2012-12-19 | Split COLO B 1:5 |
2012-12-11 | Årsstämma |
2012-11-06 | Bokslutskommuniké 2012 |
2012-08-15 | Kvartalsrapport 2012-Q3 |
2012-04-26 | Kvartalsrapport 2012-Q2 |
2012-01-25 | Kvartalsrapport 2012-Q1 |
2011-12-08 | X-dag ordinarie utdelning COLO B 14.00 DKK |
2011-12-07 | Årsstämma |
2011-11-01 | Bokslutskommuniké 2011 |
2011-08-17 | Kvartalsrapport 2011-Q3 |
2011-06-21 | Kapitalmarknadsdag 2011 |
2011-05-04 | Kvartalsrapport 2011-Q2 |
2011-01-26 | Kvartalsrapport 2011-Q1 |
2010-12-02 | X-dag ordinarie utdelning COLO B 10.00 DKK |
2009-12-02 | X-dag ordinarie utdelning COLO B 7.00 DKK |
2004-12-16 | Split COLO B 1:2 |
Beskrivning
Land | Danmark |
---|---|
Lista | Large Cap Copenhagen |
Sektor | Hälsovård |
Industri | Medicinteknik |
Coloplast, a global medical device company and leader in intimate healthcare needs, has been awarded an AscenDrive agreement with Premier, Inc. AscenDrive is a national program designed to standardize the care delivery process and help drive the highest-level commitment and savings for members. Effective July 1, 2022, Coloplast is one of two suppliers awarded the AscenDrive contract for ostomy products.
Premier is a leading healthcare improvement company uniting an alliance of approximately 4,400 U.S. hospitals and health systems and more than 225,000 other providers and organizations. With integrated data and analytics, collaboratives, supply chain solutions, and consulting and other services, Premier enables better care and outcomes at a lower cost.
“This agreement is an important milestone in our journey to establish full access in the U.S. for Coloplast, the world's No. 1 Ostomy brand. We are honored to have received this contract and look forward to working with Premier to provide products and services that create value for the AscenDrive membership,” said Manu Varma, Senior Vice President of Chronic Care North America.
About Coloplast ostomy products
Coloplast is dedicated to advancing the ostomy care industry. By continuously gathering feedback from clinicians and patients, Coloplast is able to innovate and solve daily problems for ostomy care.
Coloplast also offers additional support through the Coloplast® Care program, which provides product and lifestyle advice, inspiration, and education resources for people living with an ostomy.
About Coloplast
Danish medical device company Coloplast develops products and services designed to make life easier for people with intimate health conditions. Coloplast listens to end-users to better understand their needs and responds by bringing the best ideas to market in the form of medical devices and service solutions. Visit Coloplast.us for more information.
Global press contact
Peter Mønster, Senior Media Relations Manager
+45 4911 2623
Dkpete@coloplast.com
U.S. press contact
Kate Merwin, Head of Communications
612-286-2455
uskame@coloplast.com